723 Metabolically reprogrammed autologous Th1/Tc1 cell therapy (RAPA-201) yields promising safety and efficacy in post-PD-(L)1 solid tumor patients without lymphodepleting host conditioning

相似书籍

• 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning
  由: Martin Gutierrez, et al.
  出版: (2023-11-01)
• Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
  由: Lawrence G Lum, et al.
  出版: (2025-01-01)
• Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
  由: Murtaza S Nagree, et al.
  出版: (2022-03-01)
• Steganalysis of Quantization Index Modulation Steganography in G.723.1 Codec
  由: Zhijun Wu, et al.
  出版: (2020-01-01)
• Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen
  由: Jing Guo, et al.
  出版: (2022-02-01)